Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4484)
All Articles published online
|
Aug 15, 2003 (publication date) through Feb 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li MY, Deng H, Zhao JM, Dai D, Tan XY. Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells. World J Gastroenterol 2003; 9(8): 1683-1688 [PMID: PMC4611524 DOI: 10.3748/wjg.v9.i8.1683] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i8/1683.htm |
| Number | Citing Articles |
| 1 |
Aurora Aiello, Giuseppe Pandini, Francesco Frasca, Enrico Conte, Antonella Murabito, Antonella Sacco, Marco Genua, Riccardo Vigneri, Antonino Belfiore. Peroxisomal Proliferator-Activated Receptor-γ Agonists Induce Partial Reversion of Epithelial-Mesenchymal Transition in Anaplastic Thyroid Cancer Cells. Endocrinology 2006; 147(9): 4463 doi: 10.1210/en.2005-1610
|
| 2 |
Yvonne Y. Shao, Lai Wang, David G. Hicks, Shannon Tarr, R. Tracy Ballock. Expression and activation of peroxisome proliferator‐activated receptors in growth plate chondrocytes. Journal of Orthopaedic Research 2005; 23(5): 1139 doi: 10.1016/j.orthres.2005.02.011
|
| 3 |
A. Belfiore, M. Genua, R. Malaguarnera, Antonio Brunetti. PPAR‐γ Agonists and Their Effects on IGF‐I Receptor Signaling: Implications for Cancer. PPAR Research 2009; 2009(1) doi: 10.1155/2009/830501
|
| 4 |
Yifeng He, Haijian Li, Yunhe He, Caijie Lu, Peiyi Zhu, Mingyi Li, Juan Duan, Zhixin Fang. Troglitazone inhibits hepatic oval cell proliferation by inducing cell cycle arrest through Hippo/YAP pathway regulation. Digestive and Liver Disease 2022; 54(6): 791 doi: 10.1016/j.dld.2021.08.018
|
| 5 |
Hyo Jung Kim, Im Sun Woo, Eun Sil Kang, So Young Eun, Gil Hyeong Kim, Sun Ah Ham, Hye Jung Kim, Jae Heun Lee, Ki Churl Chang, Jin-Hoi Kim, Hoon Taek Lee, Han Geuk Seo. Phorbol ester potentiates the growth inhibitory effects of troglitazone via up-regulation of PPARγ in A549 cells. Biochemical and Biophysical Research Communications 2006; 349(2): 660 doi: 10.1016/j.bbrc.2006.08.085
|
| 6 |
Bo Zheng, Yan-Jing Zhu, Hong-Yang Wang, Lei Chen. Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanisms. Science China Life Sciences 2017; 60(6): 575 doi: 10.1007/s11427-016-9043-9
|
| 7 |
Mei Ming, Jie-Ping Yu, Xiang-Zhi Meng, Yan-Hong Zhou, Hong-Gang Yu, He-Sheng Luo. Effect of ligand troglitazone on peroxisome proliferator-activated receptor γ expression and cellular growth in human colon cancer cells. World Journal of Gastroenterology 2006; 12(45): 7263-7270 doi: 10.3748/wjg.v12.i45.7263
|
| 8 |
Liwei Wu, Chuanyong Guo, Jianye Wu. Therapeutic potential of PPARγ natural agonists in liver diseases. Journal of Cellular and Molecular Medicine 2020; 24(5): 2736 doi: 10.1111/jcmm.15028
|
| 9 |
E. Bugianesi. Non-alcoholic Steatohepatitis and Cancer. Clinics in Liver Disease 2007; 11(1): 191 doi: 10.1016/j.cld.2007.02.006
|
| 10 |
Viji M P, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, Abhishek Ghara, Pronoy Kanti Das, Manjushree B V, S Mounika, Haripriya E, Md Ashadul Sk. Exploring Thiazolidine-2,4‑dione derivatives as privileged scaffolds for targeted anticancer agents: Biological activity and structure-activity relationship (SAR) insights. Journal of Molecular Structure 2025; 1322: 140529 doi: 10.1016/j.molstruc.2024.140529
|
| 11 |
Melody Chiu, Lucien McBeth, Puneet Sindhwani, Terry D. Hinds. Deciphering the Roles of Thiazolidinediones and PPARγin Bladder Cancer. PPAR Research 2017; 2017: 1 doi: 10.1155/2017/4810672
|
| 12 |
C. Bonne. Le PPAR gamma : une nouvelle cible pharmacologique contre la néovascularisation rétinienne et choroïdienne. Journal Français d'Ophtalmologie 2005; 28(3): 326 doi: 10.1016/S0181-5512(05)81062-9
|
| 13 |
Lorne J. Hofseth, Lei Ying. Identifying and defusing weapons of mass inflammation in carcinogenesis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2006; 1765(1): 74 doi: 10.1016/j.bbcan.2005.08.005
|
| 14 |
Sharon E Campbell, William L Stone, Steven Lee, Sarah Whaley, Hongsong Yang, Min Qui, Paige Goforth, Devin Sherman, Derek McHaffie, Koyamangalath Krishnan. Comparative effects of RRR-alpha- and RRR-gamma-tocopherol on proliferation and apoptosis in human colon cancer cell lines. BMC Cancer 2006; 6(1) doi: 10.1186/1471-2407-6-13
|
| 15 |
Alexandra Rogue, Catherine Spire, Manuel Brun, Nancy Claude, André Guillouzo. Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human Liver. PPAR Research 2010; 2010: 1 doi: 10.1155/2010/325183
|
| 16 |
Marwa M. Ahmad, Noha A. Rezk, Amal Fawzy, Mohamed Sabry. Protective effects of curcumin and silymarin against paracetamol induced hepatotoxicity in adult male albino rats. Gene 2019; 712: 143966 doi: 10.1016/j.gene.2019.143966
|
| 17 |
Atef A. El-Hela, Marwa S. Abu Bakr, Mostafa M. Hegazy, Mohammed A. Dahab, Ayman Abo Elmaaty, Adel Ehab Ibrahim, Sami El Deeb, Hatem S. Abbass. Phytochemical Characterization of Pterocephalus frutescens with In-Silico Evaluation as Chemotherapeutic Medicine and Oral Pharmacokinetics Prediction Study. Scientia Pharmaceutica 2023; 91(1): 7 doi: 10.3390/scipharm91010007
|
| 18 |
Guang Jia, Yi-Qun Gu, Kung-Tung Chen, You-Yong Lu, Lei Yan, Jian-Ling Wang, Ya-Ping Su, J. C. Gaston Wu. Protective role of metallothionein (I/II) against pathological damage and apoptosis induced by dimethylarsinic acid. World Journal of Gastroenterology 2004; 10(1): 91-95 doi: 10.3748/wjg.v10.i1.91
|
| 19 |
Ivan Borbath, Yves Horsmans, Dipak Panigrahy. The Role of PPARγ in Hepatocellular Carcinoma. PPAR Research 2008; 2008(1) doi: 10.1155/2008/209520
|
| 20 |
Xudong Wu, Weichang Chen, Suqing Zhang. Peroxisome proliferator-activated receptor γ expression correlates with tumor angiogenesis in human hepatocellular carcinoma. The Chinese-German Journal of Clinical Oncology 2008; 7(5): 266 doi: 10.1007/s10330-008-0022-2
|
| 21 |
Swati Katoch, Vinesh Sharma, Vikram Patial. Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios. World Journal of Gastroenterology 2022; 28(28): 3535-3554 doi: 10.3748/wjg.v28.i28.3535
|
| 22 |
Sapana Bansod, Mohd Aslam Saifi, Chandraiah Godugu. Molecular updates on berberine in liver diseases: Bench to bedside. Phytotherapy Research 2021; 35(10): 5459 doi: 10.1002/ptr.7181
|
| 23 |
Belinda Knight, Bu B. Yeap, George C. Yeoh, John K. Olynyk. Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member γ, but not α or δ. Carcinogenesis 2005; 26(10): 1782 doi: 10.1093/carcin/bgi138
|
| 24 |
Jai Prakash, Ruchi Bansal, Eduard Post, Alie de Jager-Krikken, Marjolijn N. Lub-de Hooge, Klaas Poelstra. Albumin-Binding and Tumor Vasculature Determine the Antitumor Effect of 15-Deoxy-Δ12,14-Prostaglandin-J2in vivo. Neoplasia 2009; 11(12): 1348 doi: 10.1593/neo.91188
|
| 25 |
YUEH-MIN LIN, BHARATH KUMAR VELMURUGAN, YU-LAN YEH, CHUAN CHOU TU, TSUNG-JUNG HO, TUNG YUAN LAI, CHIH-HAO TSAI, FUU JEN TSAI, CHANG-HAI TSAI, CHIH-YANG HUANG. Activation of estrogen receptors with E2 downregulates peroxisome proliferator-activated receptor γ in hepatocellular carcinoma. Oncology Reports 2013; 30(6): 3027 doi: 10.3892/or.2013.2793
|
| 26 |
Cai-Yan Zhao, Ling-Ling Jiang, Li Li, Zhuo-Jun Deng, Bao-Li Liang, Jian-Mei Li. Peroxisome proliferator activated receptor-γ in pathogenesis of experimental fatty liver disease. World Journal of Gastroenterology 2004; 10(9): 1329-1332 doi: 10.3748/wjg.v10.i9.1329
|